Meridigen provides MSC as well as a wide range of research services including trials design, trials implementation, assessment of cell-based drugs, and analysis of biomedical data. Since 2015, Meridigen Biotech Co., Ltd. has been operating a stem-cell-drug factory. The pharmaceutical factory is entirely constructed and operated based on the international standard PIC/S GMP that ensure the maintaining of high standards of quality assurance in the development and manufacturing. We use the highest standard facilities and our patented technique “MSCs scaling up platform” to produce MSC products. Each batch of our products must pass multiple assessments to produce qualifying reports, in order to supply with the best quality to our R&D team, and customers domestically and overseas.

Mesenchymal Stem Cell

• Human umbilical cord derived MSC (hUC-MSC)
• Human chorionic disk derived MSC (hCD-MSC)
• Human amniotic membrane derived MSC (hAM-MSC)
• Human chorionic membrane derived MSC (hCM-MSC)
• Pre-term human umbilical cord derived MSC (Pre-term hUC-MSC)

Contact Us

E-mail：contract_service@meridigen.com

Tel：02-2627-5175